BiFeO 3 powder was synthesized in NaCl media at temperature range from 700 to 800°C, using Bi 2 O 3 and Fe 2 O 3 as raw materials. Effects of calcining temperature and salt ratios on the synthesis of BiFeO 3 powder had been investigated. It was found that NaCl effectively promoted the formation of BiFeO 3 . Almost pure BiFeO 3 phase with a very small amount of Bi 2 Fe 4 O 9 phase was synthesized at 750°C with salt weight ratios of 1:1. A large amount of BiFeO 3 phase decomposed to Bi 2 Fe 4 O 9 and Bi 25 FeO 39 phase when the temperature was up to 800°C. In the present method, the calcining temperature played an important role in the formation of BiFeO 3 phase. BiFeO 3 ceramics derived from molten salt method were prepared and exhibited the higher dielectric constant.
The effects of Ti-doping on the decomposition behavior, crystal structure, sintering behavior and dielectric properties have been investigated for the Ti-doped BiFeO 3 ceramics derived from molten salt method. XRD reveals the almost pure phase BiFeO 3 is synthesized in the Tidoped BiFeO 3 powders. And the particle size of Ti-doped BiFeO 3 powers obviously decreases with the increase of Ti content. However, the sintering temperature elevates significantly after Ti-doping. The DC resistivity can enhance by up to four orders of magnitude (from 10 4 to 10 8 Xm) with only 5 at% Ti doping. But the dielectric constant is suppressed from 10 4 to 10 2 , and dielectric loss obviously reduces with a small amount of Ti doping. The variation of dielectric properties has been discussed from the decomposition of BiFeO 3 phase. The Ti-doping can effectively suppress the decomposition reaction in Ti-doped BiFeO 3 ceramics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.